Organic Process Research & Development 2009, 13, 857–862
Investigation on the Formation and Hydrolysis of N,N-Dimethylcarbamoyl Chloride
(DMCC) in Vilsmeier Reactions Using GC/MS as the Analytical Detection Method
Martina Stare, Krzysztof Laniewski, Andreas Westermark, Magnus Sj o¨ gren, and Wei Tian*
Global Process R&D S o¨ dert a¨ lje, AstraZeneca, 151 85 S o¨ dert a¨ lje, Sweden
Abstract:
Scheme 1. Chlorine replacement of a hydroxyl group by
Vilsmeier reagent 1
The formation of N,N-dimethylcarbamoyl chloride (DMCC) in
Vilsmeier reactions (VRs) and the hydrolysis of DMCC during
aqueous workup were investigated. The amount of DMCC formed
was dependent on the chlorination reagent. The activity order was
found to be: thionyl chloride > oxalyl chloride > phosphorus
oxychloride. The concentrations of DMCC found in the tested
reactions were normally at a level of 0-20 ppm. In the presence
of a base the level was higher. DMCC hydrolyzed quickly under
aqueous workup conditions. No more than 3 ppm of DMCC could
be detected in the product after aqueous workup of the tested VR.
Our results clearly indicate that by following the described
procedure for VR it is perfectly safe from the health risk point of
view to operate this chemistry when preparing compounds for
pharmaceutical use. A very useful analytical procedure for
detection and quantification of trace amounts of DMCC formed
in the VR was developed. The method was based on derivatization
of DMCC with ethanol to form ethyl N,N-dimethylcarbamate and
analysis by GC coupled to a mass spectrometer in selected ion
monitoring mode. The analytical method was selective and showed
very good linearity. The limit of detection (LOD) and limit of
quantification (LOQ) of DMCC using standard addition analysis
with real Vilsmeier reaction matrices were determined to be LOD
6
by D. Levin in light of the fact that DMCC is a potential
carcinogen according to the International Agency for Research
on Cancer (IARC) evaluations. During the last five years an
increased interest regarding potential genotoxic impurities
7,8
(
PGIs) has emerged from health authorities and the phamaceu-
tical industry. PGIs have had such an impact that process
chemists must consider changing the reagent(s), choosing
another route or applying a control strategy to eliminate any
PGIs. At the moment there is inadequate evidence for carci-
nogenicity of DMCC in humans, although there is sufficient
evidence for carcinogenicity in animals. Thus, DMCC generated
in an organic process for the manufacturing of an API can be
defined as a PGI. The permitted level is dependent on the daily
9,10
dose, but DMCC is normally only allowed in ppm levels,
which puts challenges into the analytical methods.
The concerns around the formation of DMCC under the VR
conditions have resulted in restricted application of the VR in
the process development of pharmaceuticals even though little
is reported as to how much or about how much DMCC is really
generated during the reactions. In an ongoing project, we
decided to apply the VR in the penultimate step, the chlorination
of 2 for the synthesis of 5 (Scheme 2). In the process, DMF is
utilized both as a protecting agent for the formation of the
hydroxyl amidine 3 and as a catalyst for the Vilsmeier
chlorination of 3 to generate the chlorinated amidine 4 (Scheme
)
0.2 ppm and LOQ ) 0.7 ppm.
Introduction
The Vilsmeier reaction (VR), or Vilsmeier-Haack reaction,
1,2
has a large range of applications in organic synthesis. One of
the most important applications is the chlorination of an alcohol
as is shown in Scheme 1. The actual chlorination reactant is
the in situ generated Vilsmeier reagent 1, which is formed by
reaction of the chlorination agent and N,N-dimethylformamide
2
). In order to assess the health safety risk of the process before
scaling it up into the pilot scale we decided to determine the
amount of DMCC generated under the reaction conditions
employed.
A survey of the literature revealed that there was neither a
suitable analytical method nor data available for the detection
(
DMF), the latter normally present in catalytic amounts.3
N,N-dimethylcarbamoyl chloride, also called DMCC, is an
active alkylating agent and has been used as an intermediate in
the manufacture of a number of pharmaceuticals and pesti-
cides.The formation of DMCC under VR conditions was
4,5
reported as early as the 1960s. The health safety concerns
regarding the application of VR in organic synthesis was raised
(
(
(
6) Levin, D. Org. Process Res. DeV. 1997, 1, 182.
7) IARC Monograph 1999, Vol. 71, pp 531-543.
8) Lohman, P. H. M. Mutat. Res. 1999, 428, 237–254.
*
To whom correspondence should be addressed. Wei Tian, PR&D Astra-
(9) M u¨ ller, L.; Mauthe, R. J.; Riley, C. M.; Andino, M. M.; Antonis, D. D.;
Beels, C.; DeGeorge, J.; De Knaep, A. G.; Ellison, D.; Fagerland,
J. A.; Frank, R.; Fritschel, B.; Galloway, S.; Harpur, E.; Humfrey,
C. D.; Jacks, A. S.; Jagota, N.; Mackinnon, J.; Mohan, G.; Ness, D. K.;
O’Donovan, M. R.; Smith, M. D.; Vudathala, G.; Yotti, L. Reg.
Toxicol. Pharmacol. 2006, 44, 198–211.
Zeneca, R&D S o¨ dert a¨ lje SE-15185, Sweden. Telephone: +46 8 553 251 83.
Fax: +46 8 553 242 76. E-mail: wei.tian@astrazeneca.com.
(
(
(
1) Qian, D. Q.; Cao, R. Z.; Liu, L. Z. Youji Huaxue 2000, 20, 30–43.
2) Marson, C. M. Tetrahedron 1992, 48, 3659–3726.
3) Hepburn, D. R.; Hudson, H. R. J. Chem. Soc., Perkin Trans. I 1976,
7
54–757.
(10) Question & Aswers on the CHMP Guideline on the Limits on
Genotoxic Impurities. EMEA/CHMP/SWP/431994/2007, revision 1;
European Medicines Agency (EMEA): London, UK, 26 June 2008.
(
(
4) K u¨ hle, E. Angew. Chem., Int. Ed.Engl. 1962, 1 (12), 647–652.
5) Hasserodt, U. Chem. Ber. 1968, 101, 113–120.
1
0.1021/op900018f CCC: $40.75 2009 American Chemical Society
Vol. 13, No. 5, 2009 / Organic Process Research & Development
•
857
Published on Web 07/02/2009